Dapsone in immunoglobulin A–associated vasculitis
MGB, SAGL, and GPM conceptualized the study. VR and POR wrote the first version of the manuscript. GPR critically revised the manuscript. All authors read and approved the final version of the manuscript.
Compliance with ethical statements
Conflict of interest
The authors declare that they have no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
- 3.Milani GP, Lava SAG, Ramelli V, Bianchetti MG (2017) Prevalence and characteristics of nonblanching, palpable skin lesions with a linear pattern in children with Henoch-Schönlein syndrome. JAMA Dermatol 153:1170–1173. https://doi.org/10.1001/jamadermatol.2017.2105 CrossRefPubMedPubMedCentralGoogle Scholar
- 5.Ramelli GP, Bianchetti MG (1997) Dapsone in cutaneous Henoch-Schönlein syndrome - worth a trial. Acta Paediatr 86:337. https://doi.org/10.1111/j.1651-2227.1997.tb08907.x CrossRefPubMedGoogle Scholar